Literature DB >> 25249153

Intrauterine growth restriction is associated with structural alterations in human umbilical cord and decreased nitric oxide-induced relaxation of umbilical vein.

A-C Peyter1, F Delhaes2, D Baud3, Y Vial3, G Diaceri2, S Menétrey2, P Hohlfeld3, J-F Tolsa2.   

Abstract

INTRODUCTION: Intrauterine growth restriction (IUGR) affects ∼8% of all pregnancies and is associated with major perinatal mortality and morbidity, and with an increased risk to develop cardiovascular diseases in adulthood. Despite identification of several risk factors, the mechanisms implicated in the development of IUGR remain poorly understood. In case of placental insufficiency, reduced delivery of oxygen and/or nutrients to the fetus could be associated with alterations in the umbilical circulation, contributing further to the impairment of maternal-fetal exchanges. We compared the structural and functional properties of umbilical cords from growth-restricted and appropriate for gestational age (AGA) term newborns, with particular attention to the umbilical vein (UV).
METHODS: Human umbilical cords were collected at delivery. Morphological changes were investigated by histomorphometry, and UV's reactivity by pharmacological studies.
RESULTS: Growth-restricted newborns displayed significantly lower growth parameters, placental weight and umbilical cord diameter than AGA controls. Total cross-section and smooth muscle areas were significantly smaller in UV of growth-restricted neonates than in controls. Maximal vasoconstriction achieved in isolated UV was lower in growth-restricted boys than in controls, whereas nitric oxide-induced relaxation was significantly reduced in UV of growth-restricted girls compared to controls.
CONCLUSION: IUGR is associated with structural alterations of the UV in both genders, and with a decreased nitric oxide-induced relaxation in UV of newborn girls, whereas boys display impaired vasoconstriction. Further investigations will allow to better understand the regulation of umbilical circulation in growth-restricted neonates, which could contribute to devise potential novel therapeutic strategies to prevent or limit the development of IUGR.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Human umbilical vein; Intrauterine growth restriction; Morphometry; Nitric oxide; Umbilical cord; Vasodilatation

Mesh:

Substances:

Year:  2014        PMID: 25249153     DOI: 10.1016/j.placenta.2014.08.090

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  5 in total

1.  Association of coexisting morphological umbilical cord abnormality and clinical cord compromise with hypoxic and thrombotic placental histology.

Authors:  Jerzy Stanek
Journal:  Virchows Arch       Date:  2016-03-16       Impact factor: 4.064

2.  The structural and functional effects of fine particulate matter from cooking oil fumes on rat umbilical cord blood vessels.

Authors:  Xiaoxia Zhu; Lijuan Hou; Jian Zhang; Cijiang Yao; Ying Liu; Chao Zhang; Yachun Xu; Jiyu Cao
Journal:  Environ Sci Pollut Res Int       Date:  2016-05-13       Impact factor: 4.223

3.  Whole organ vascular casting and microCT examination of the human placental vascular tree reveals novel alterations associated with pregnancy disease.

Authors:  Toluwalope O Junaid; Robert S Bradley; Rohan M Lewis; John D Aplin; Edward D Johnstone
Journal:  Sci Rep       Date:  2017-06-23       Impact factor: 4.379

4.  Proteomic analysis of the umbilical cord in fetal growth restriction and preeclampsia.

Authors:  Matthew S Conrad; Miranda L Gardner; Christine Miguel; Michael A Freitas; Kara M Rood; Marwan Ma'ayeh
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

5.  Hyperactivation of Wnt/β-catenin and Jak/Stat3 pathways in human and zebrafish foetal growth restriction models: Implications for pharmacological rescue.

Authors:  Giovanni Risato; Rudy Celeghin; Raquel Brañas Casas; Alberto Dinarello; Alessandro Zuppardo; Andrea Vettori; Kalliopi Pilichou; Gaetano Thiene; Cristina Basso; Francesco Argenton; Silvia Visentin; Erich Cosmi; Natascia Tiso; Giorgia Beffagna
Journal:  Front Cell Dev Biol       Date:  2022-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.